U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Approval Year

Unknown
149124
Name Type Language
ociperlimab [INN]
Preferred Name English
OCIPERLIMAB
USAN   INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR TIGIT) (HUMAN-MUS MUSCULUS MONOCLONAL BGB-A1217 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BGB-A1217 .KAPPA.-CHAIN, DIMER
Common Name English
OCIPERLIMAB [USAN]
Common Name English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TIGIT (T-CELL IMMUNORECEPTOR WITH IG DOMAIN AND ITIM, V-SET IG MEMBER 9, VSIG9, V-SET AND TRANSMEMBRANE MEMBER 3, VSTM3)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN HUMANIZED (1-449) (VH (HOMO SAPIENS I
Common Name English
BGB-A1217
Code English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS TIGIT (T-CELL IMMUNORECEPTOR WITH IG DOMAIN AND ITIM, V-SET IG MEMBER 9, VSIG9, V-SET AND TRANSMEMBRANE MEMBER 3, VSTM3)), HUMANIZED MONOCLONAL ANTIBODY (OCIPERLIMAB)
Common Name English
Ociperlimab [WHO-DD]
Common Name English
BGBA-1217
Code English
BGBA1217
Code English
Code System Code Type Description
NCI_THESAURUS
C170906
Created by admin on Wed Apr 02 07:30:03 GMT 2025 , Edited by admin on Wed Apr 02 07:30:03 GMT 2025
PRIMARY
CAS
2342597-93-5
Created by admin on Wed Apr 02 07:30:03 GMT 2025 , Edited by admin on Wed Apr 02 07:30:03 GMT 2025
PRIMARY
INN
11452
Created by admin on Wed Apr 02 07:30:03 GMT 2025 , Edited by admin on Wed Apr 02 07:30:03 GMT 2025
PRIMARY
FDA UNII
7JNY4KV3NK
Created by admin on Wed Apr 02 07:30:03 GMT 2025 , Edited by admin on Wed Apr 02 07:30:03 GMT 2025
PRIMARY
SMS_ID
300000026757
Created by admin on Wed Apr 02 07:30:03 GMT 2025 , Edited by admin on Wed Apr 02 07:30:03 GMT 2025
PRIMARY
USAN
JK-219
Created by admin on Wed Apr 02 07:30:03 GMT 2025 , Edited by admin on Wed Apr 02 07:30:03 GMT 2025
PRIMARY
ACTIVE MOIETY
OCIPERLIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966